• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新的用于合成抑制芳香化酶并与雌激素受体α和β结合的三苯乙烯类化合物的铃木反应。

A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.

作者信息

Zhao Li-Ming, Jin Hai-Shan, Liu Jinzhong, Skaar Todd C, Ipe Joseph, Lv Wei, Flockhart David A, Cushman Mark

机构信息

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, and The Purdue University Center for Cancer Research, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, United States; School of Chemistry and Chemical Engineering, and Jiangsu Key Laboratory of Green Synthetic Chemistry for Functional Materials, Jiangsu Normal University, Xuzhou 221116, Jiangsu, China.

Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indiana Institute for Personalized Medicine, Indianapolis, IN 46202, United States.

出版信息

Bioorg Med Chem. 2016 Nov 1;24(21):5400-5409. doi: 10.1016/j.bmc.2016.08.064. Epub 2016 Aug 31.

DOI:10.1016/j.bmc.2016.08.064
PMID:27647367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5065788/
Abstract

The design and synthesis of dual aromatase inhibitors/selective estrogen receptor modulators (AI/SERMs) is an attractive strategy for the discovery of new breast cancer therapeutic agents. Previous efforts led to the preparation of norendoxifen (4) derivatives with dual aromatase inhibitory activity and estrogen receptor binding activity. In the present study, some of the structural features of the potent AI letrozole were incorporated into the lead compound (norendoxifen) to afford a series of new dual AI/SERM agents based on a symmetrical diphenylmethylene substructure that eliminates the problem of E,Z isomerization encountered with norendoxifen-based AI/SERMs. Compound 12d had good aromatase inhibitory activity (IC=62.2nM) while also exhibiting good binding activity to both ER-α (EC=72.1nM) and ER-β (EC=70.8nM). In addition, a new synthesis was devised for the preparation of norendoxifen and its analogues through a bis-Suzuki coupling strategy.

摘要

设计和合成双功能芳香酶抑制剂/选择性雌激素受体调节剂(AI/SERMs)是发现新型乳腺癌治疗药物的一种有吸引力的策略。先前的研究工作已制备出具有双功能芳香酶抑制活性和雌激素受体结合活性的去甲烯诺昔芬(4)衍生物。在本研究中,将强效AI来曲唑的一些结构特征引入先导化合物(去甲烯诺昔芬)中,以得到一系列基于对称二苯基亚甲基结构的新型双功能AI/SERM药物,该结构消除了基于去甲烯诺昔芬的AI/SERMs所遇到的E,Z异构化问题。化合物12d具有良好的芳香酶抑制活性(IC = 62.2nM),同时对雌激素受体α(EC = 72.1nM)和雌激素受体β(EC = 70.8nM)均表现出良好的结合活性。此外,还设计了一种通过双铃木偶联策略制备去甲烯诺昔芬及其类似物的新合成方法。

相似文献

1
A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.一种新的用于合成抑制芳香化酶并与雌激素受体α和β结合的三苯乙烯类化合物的铃木反应。
Bioorg Med Chem. 2016 Nov 1;24(21):5400-5409. doi: 10.1016/j.bmc.2016.08.064. Epub 2016 Aug 31.
2
Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.作为芳香酶抑制剂且能调节雌激素受体的三苯乙烯双酚的合成。
J Med Chem. 2016 Jan 14;59(1):157-70. doi: 10.1021/acs.jmedchem.5b01677. Epub 2015 Dec 24.
3
Synthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities.合成具有双重芳香酶抑制和雌激素受体调节活性的混合(E,Z)-、(E)-和(Z)-去甲诺龙。
J Med Chem. 2013 Jun 13;56(11):4611-8. doi: 10.1021/jm400364h. Epub 2013 Jun 3.
4
Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.具有双重芳香酶抑制和雌激素受体调节活性的去甲烯氧苯内酯类似物的设计与合成。
J Med Chem. 2015 Mar 26;58(6):2623-48. doi: 10.1021/jm501218e. Epub 2015 Mar 9.
5
Discovery of a multi-target compound for estrogen receptor-positive (ER) breast cancer: Involvement of aromatase and ERs.发现一种针对雌激素受体阳性(ER)乳腺癌的多靶化合物:涉及芳香酶和 ERs。
Biochimie. 2021 Feb;181:65-76. doi: 10.1016/j.biochi.2020.11.023. Epub 2020 Dec 3.
6
Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors.采用水相 Wittig 方法合成α-甲基二苯乙烯,并将其应用于开发有效的人芳香酶抑制剂。
Bioorg Med Chem Lett. 2019 Jun 1;29(11):1395-1398. doi: 10.1016/j.bmcl.2019.03.033. Epub 2019 Mar 26.
7
Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.优化白藜芦醇吡啶噻唑类似物的芳香酶抑制活性。
Bioorg Med Chem. 2012 Apr 1;20(7):2427-34. doi: 10.1016/j.bmc.2012.01.047. Epub 2012 Feb 11.
8
Potent aromatase inhibitors and molecular mechanism of inhibitory action.强效芳香酶抑制剂及其抑制作用的分子机制。
Eur J Med Chem. 2018 Jan 1;143:426-437. doi: 10.1016/j.ejmech.2017.11.057. Epub 2017 Nov 22.
9
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents.他莫昔芬代谢物诺雷德芬是一种强效且选择性的芳香酶(CYP19)抑制剂,也是新型治疗药物的潜在先导化合物。
Breast Cancer Res Treat. 2012 May;133(1):99-109. doi: 10.1007/s10549-011-1699-4. Epub 2011 Aug 4.
10
Novel chloropyridazine sulfonamides as aromatase inhibitors and apoptotic inducers in breast cancer.新型氯哒嗪磺酰胺类化合物作为乳腺癌中的芳香化酶抑制剂和凋亡诱导剂
Bioorg Chem. 2025 Jun 15;160:108470. doi: 10.1016/j.bioorg.2025.108470. Epub 2025 Apr 15.

引用本文的文献

1
New Promising Steroidal Aromatase Inhibitors with Multi-Target Action on Estrogen and Androgen Receptors for Breast Cancer Treatment.新型有前景的甾体芳香酶抑制剂对雌激素和雄激素受体具有多靶点作用,用于乳腺癌治疗。
Cancers (Basel). 2025 Jan 7;17(2):165. doi: 10.3390/cancers17020165.
2
Aromatase Inhibitors as a Promising Direction for the Search for New Anticancer Drugs.芳香酶抑制剂作为寻找新型抗癌药物的一个有希望的方向。
Molecules. 2024 Jan 10;29(2):346. doi: 10.3390/molecules29020346.
3
An Exemestane Derivative, Oxymestane-D1, as a New Multi-Target Steroidal Aromatase Inhibitor for Estrogen Receptor-Positive (ER) Breast Cancer: Effects on Sensitive and Resistant Cell Lines.

本文引用的文献

1
Synthesis of Triphenylethylene Bisphenols as Aromatase Inhibitors That Also Modulate Estrogen Receptors.作为芳香酶抑制剂且能调节雌激素受体的三苯乙烯双酚的合成。
J Med Chem. 2016 Jan 14;59(1):157-70. doi: 10.1021/acs.jmedchem.5b01677. Epub 2015 Dec 24.
2
Synthesis and evaluation of tamoxifen derivatives with a long alkyl side chain as selective estrogen receptor down-regulators.具有长烷基侧链的他莫昔芬衍生物作为选择性雌激素受体下调剂的合成与评价
Bioorg Med Chem. 2015 Jul 1;23(13):3091-6. doi: 10.1016/j.bmc.2015.05.002. Epub 2015 May 11.
3
Design and synthesis of norendoxifen analogues with dual aromatase inhibitory and estrogen receptor modulatory activities.
一种依西美坦衍生物,奥塞米坦-D1,作为一种新的多靶点甾体芳香酶抑制剂用于雌激素受体阳性(ER)乳腺癌:对敏感和耐药细胞系的影响。
Molecules. 2023 Jan 12;28(2):789. doi: 10.3390/molecules28020789.
4
2,2'-Bipyridine-Modified Tamoxifen: A Versatile Vector for Molybdacarboranes.2,2'-联吡啶修饰的他莫昔芬:一种多功能钼卡宾的载体。
ChemMedChem. 2019 Dec 17;14(24):2075-2083. doi: 10.1002/cmdc.201900554. Epub 2019 Nov 18.
5
Estrogen alpha receptor antagonists for the treatment of breast cancer: a review.用于治疗乳腺癌的雌激素α受体拮抗剂:综述
Chem Cent J. 2018 Oct 25;12(1):107. doi: 10.1186/s13065-018-0472-8.
具有双重芳香酶抑制和雌激素受体调节活性的去甲烯氧苯内酯类似物的设计与合成。
J Med Chem. 2015 Mar 26;58(6):2623-48. doi: 10.1021/jm501218e. Epub 2015 Mar 9.
4
Structure-activity relationship study of diphenylamine-based estrogen receptor (ER) antagonists.基于二苯胺的雌激素受体(ER)拮抗剂的构效关系研究
Bioorg Med Chem. 2015 Feb 15;23(4):861-7. doi: 10.1016/j.bmc.2014.12.022. Epub 2015 Jan 6.
5
Selenium analogues of raloxifene as promising antiproliferative agents in treatment of breast cancer.雷洛昔芬的硒类似物作为治疗乳腺癌的有前景的抗增殖剂。
Eur J Med Chem. 2014 Nov 24;87:471-83. doi: 10.1016/j.ejmech.2014.09.088. Epub 2014 Sep 30.
6
The evolution of nonsteroidal antiestrogens to become selective estrogen receptor modulators.非甾体类抗雌激素药物向选择性雌激素受体调节剂的演变。
Steroids. 2014 Nov;90:3-12. doi: 10.1016/j.steroids.2014.06.009. Epub 2014 Jun 17.
7
An overview of current and emerging SERMs.当前及新型选择性雌激素受体调节剂概述
J Steroid Biochem Mol Biol. 2014 Sep;143:207-22. doi: 10.1016/j.jsbmb.2014.03.003. Epub 2014 Mar 22.
8
Design and synthesis of tamoxifen derivatives as a selective estrogen receptor down-regulator.设计和合成他莫昔芬衍生物作为一种选择性雌激素受体下调剂。
Bioorg Med Chem Lett. 2014 Jan 1;24(1):87-9. doi: 10.1016/j.bmcl.2013.11.078. Epub 2013 Dec 4.
9
Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifen.e-和 z-异构体诺(endoxifen)对细胞色素 p450 酶的抑制作用。
Drug Metab Dispos. 2013 Sep;41(9):1715-20. doi: 10.1124/dmd.113.052506. Epub 2013 Jul 3.
10
Synthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities.合成具有双重芳香酶抑制和雌激素受体调节活性的混合(E,Z)-、(E)-和(Z)-去甲诺龙。
J Med Chem. 2013 Jun 13;56(11):4611-8. doi: 10.1021/jm400364h. Epub 2013 Jun 3.